Erectile Dysfunction clinical trials
The registry lists 701 studies for Erectile Dysfunction across more than 10 countries. 125 are recruiting or about to start. 562 of them are mainly about Erectile Dysfunction (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
ClinicalTrials.gov finds 751 studies for Erectile Dysfunction. How that becomes 701 here
This page counts the studies the registry files under Erectile Dysfunction, and those it files under no condition that list Erectile Dysfunctionthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 751Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −20List Erectile Dysfunction as a condition, but the registry did not file them under itMost often written as “Erectile Dysfunction Following Radical Prostatectomy” (13), “Erectile Dysfunction Associated With Type 2 Diabetes Mellitus” (2), and “Erectile Dysfunction With Diabetes Mellitus” (2). The registry filed them under other conditions only, most often Prostatic Neoplasms (13) and Urinary Incontinence (3).
- −30Match it another way25 name it in the title, 1 in a keyword, and 4 by a synonym or other text the search reads.
- 701The count on this page30 of them list Erectile Dysfunction in their own words; the registry filed them under no condition.
Get an email when these change. Save the Erectile Dysfunction studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Bayer (51) · Eli Lilly and Company (28) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (27) · Cairo University (17) · VIVUS LLC (15) · Rambam Health Care Campus (14) · Vigonvita Life Sciences (10) · Institute for the Study of Urological Diseases, Greece (9)
What is being tested here
Drugs under test in Erectile Dysfunction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tadalafil | 8 | 20 | 56 |
| Platelet rich plasma | 2 | 1 | 10 |
| Sildenafil | 1 | 6 | 50 |
| BZ-371A | 1 | 0 | 2 |
| NOS Enhancer BZ371A | 1 | 0 | 2 |
| Solizmestrocel | 1 | 1 | 2 |
| 68Ga-FAPI | 1 | 0 | 1 |
| YN001 | 1 | 0 | 1 |
| Citrulline | 1 | 0 | 1 |
| 4-Aminopyridine | 1 | 1 | 1 |
Drug classes tested here PDE5 inhibitors 8 open · Androgens 9 · Statins 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jul 2027The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505. · Phase 3 · GL Pharm Tech Corporation
- Jul 20274-aminopyridine Treatment for Nerve Injury · Phase 3 · John Elfar
- Jul 2027SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) · Phase 3 · Icahn School of Medicine at Mount Sinai
- Sep 2027A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients · Phase 3 · Hanmi Pharmaceutical Company Limited
- Nov 2026L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction · Beni-Suef University
- Nov 2026Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction. · Camilo Jose Cela University
- Nov 2026Treatment With Peripheral Nerve Stimulation of the Pudendal Nerve in Patients With Erectile Dysfunction · Camilo Jose Cela University
- Dec 2026Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease · Mayo Clinic
- Dec 2026Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain · The Cleveland Clinic
- Dec 2026A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia · Azienda USL Reggio Emilia - IRCCS
Who these studies take
Of the 78 Erectile Dysfunction studies recruiting now, 31 (40%) set no upper age limit and 34 (44%) stop at 75 or younger. 2 (3%) take children under 18. 3 (4%) are for women only and 71 (91%) for men only; 7 (9%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (1%) | 2 (3%) |
| 18 | 6 (8%) | 35 (45%) |
| 30 | 6 (8%) | 57 (73%) |
| 40 | 7 (9%) | 74 (95%) |
| 50 | 7 (9%) | 70 (90%) |
| 65 | 7 (9%) | 68 (87%) |
| 75 | 7 (9%) | 53 (68%) |
| 85 | 6 (8%) | 33 (42%) |
Across all 701 studies, recruiting or not: 49% stop at 75 or younger and 29% at 65; 4% take children; 1% are for women only and 95% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Erectile Dysfunction studies take
Of 24 phase 2 interventional studies under Erectile Dysfunction, half reached primary completion within 28 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 5 mo1–19 · 18 studies | — | — |
| Phase 2 | 28 mo16–32 · 24 studies | — | — |
| Phase 3 | 25 mo10–30 · 16 studies | — | — |
| Phase 4 | 11 mo8–27 · 16 studies | — | — |
| Interventional, no phase | 32 mo14–52 · 137 studies | — | 30 mo15–52 · 115 studies |
| Observational | 36 mo12–77 · 40 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting3
- Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer TreatmentNov 6, 2026NCT07685249
- Platelet-Rich Plasma for Erectile Dysfunction After Radical ProstatectomyNov 6, 2026NCT07863388
- Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile DysfunctionOct 16, 2026NCT07604194
Stopped1
- Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial CystitisTerminatedOct 20, 2026NCT05147779
Newly registered5
- Retrospective Analysis of Erectile Dysfunction (ED) Patients Based on a Large-scale Clinical DatabaseNov 3, 2026NCT07913477
- Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's DiseaseOct 29, 2026NCT07903987
- Investigation of Serum Sclerostin Levels in Patients With Erectile DysfunctionOct 28, 2026NCT07902362
- A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsOct 27, 2026NCT07899073
- Erectile and Ejaculatory Function Following Coronary RevascularizationOct 16, 2026NCT07878260
Studies
Recruiting first, then most recently updated. Showing 50 of 701. Browse all 701 → or search them.
- Platelet-Rich Plasma for Erectile Dysfunction After Radical ProstatectomyRecruitingNCT07863388Not applicable1 country
- Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer TreatmentRecruitingNCT07685249Not applicable1 country
- Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's DiseaseRecruitingNCT07903987Phase 41 country
- A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsRecruitingNCT07899073Phase 31 country
- Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical ProstatectomyRecruitingNCT07576335Phase 21 country
- Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's DiseaseRecruitingNCT06065436Not applicable1 country
- Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile DysfunctionRecruitingNCT07604194Not applicable1 country
- IT Matters: The Erectile Restoration RegistryEnrolling by invitationNCT042009373 countries
- Male Pelvic Floor Muscle Rehabilitation ExercisesNot yet recruitingNCT07451808Not applicable
- The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.Not yet recruitingNCT07859202Phase 31 country
- Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery DiseaseRecruitingNCT07856199Not applicable1 country
- Shockwave Therapy on Treating Erectile Dysfunction Following Nerve-sparing Radical Prostatectomy.Not yet recruitingNCT07819084Not applicable1 country
- Tractography-Guided Nerve-Sparing in Prostate CancerRecruitingNCT07847385Not applicable1 country
- AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary HypogonadismEnrolling by invitationNCT07761546Not applicable1 country
- IPP Placement & Intracavernosal BlockNot yet recruitingNCT07246642Phase 41 country
- Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile DysfunctionRecruitingNCT07311330Phase 21 country
- EECP for Erectile Dysfunction in Elderly Hypertensive PatientsNot yet recruitingNCT07831551Not applicable1 country
- Linear Piezoelectric Low Intensity Shockwave Treatment (LI-SWT) for the Treatment of Erectile Dysfunction in PDE5i Non ResponderRecruitingNCT07820748Not applicable1 country
- Assessment of Erectile Dysfunction and Coronary Artery Disease SeverityNot yet recruitingNCT07813195
- Penile Lengthening Pre-Penile Prosthesis ImplantationRecruitingNCT07053826Not applicable1 country
- Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile DysfunctionRecruitingNCT07753720Phase 41 country
- Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-ProstatectomyRecruitingNCT05244486Not applicable1 country
- A Survey of Traditional Medicine Pattern Identification in Patients With Erectile DysfunctionRecruitingNCT074871811 country
- Male Sexual Function and Sexual Quality of Life in Polygamous Versus Monogamous MarriagesRecruitingNCT077839581 country
- Platelet-Rich Plasma Alone Versus PRP Plus Low-Intensity Shock Wave Therapy for Erectile DysfunctionNot yet recruitingNCT07783347Not applicable1 country
- Endothelial Markers and Tadalafil ResponseRecruitingNCT077731031 country
- Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic PainRecruitingNCT05868668Not applicable1 country
- Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile DysfunctionNot yet recruitingNCT07537855Phase 2
- Lifestyle Modification for Erectile Dysfunction in Men With Metabolic SyndromeRecruitingNCT07758842Not applicable1 country
- Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile DysfunctionRecruitingNCT07273773Not applicable1 country
- Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)RecruitingNCT05574868Not applicable1 country
- Diagnostic Performance of a Flexible Penile Monitoring System for EDNot yet recruitingNCT077624691 country
- A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid LeukemiaRecruitingNCT070611451 country
- Comparison Between Excision And Primary Anastomosis Urethroplasty And Tunica Vaginalis Graft Urethroplasty.Not yet recruitingNCT07668973Not applicable
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and CabergolineNot yet recruitingNCT07732387Phase 11 country
- Does Erectile Dysfonction Allow to Evaluate Subendocardial Viability Among Treated Patients With Hypertension ?Not yet recruitingNCT077197901 country
- Intracavernosal Exosomes vs. Rectal Ozone for Post-RARP Erectile DysfunctionNot yet recruitingNCT07707505Not applicable1 country
- Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate CancerEnrolling by invitationNCT076936471 country
- Stem Cells for Erectile Dysfunction Post RALPRecruitingNCT07048314Phase 1/21 country
- L-Citrulline and Tadalafil for Mild to Moderate Erectile DysfunctionRecruitingNCT07642505Phase 41 country
- Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)RecruitingNCT004993171 country
- A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile DysfunctionRecruitingNCT07601646Phase 21 country
- EVERiST: Impact of Image Detected Accessory Pudendal Artery on Erection Recovery After Nerve Sparing ProstatectomyRecruitingNCT075977981 country
- A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile DysfunctionRecruitingNCT07592533Not applicable1 country
- Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryRecruitingNCT02706561Not applicable1 country
- Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile DysfunctionRecruitingNCT07480161Phase 2/31 country
- TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in MenRecruitingNCT07460960Phase 21 country
- PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate CancerNot yet recruitingNCT074607261 country
- The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature EjaculationRecruitingNCT07442396Not applicable1 country
- Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile DysfunctionRecruitingNCT074310081 country